The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors

Zurich, Switzerland and Dortmund, Germany – 4 December 2018 – The European Organization for Research and Treatment of Cancer (EORTC) Brain Tumor Group and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors. Glioblastoma is the most... Read more

Cofactor Genomics to Provide Solid Tumor Immune Profiling for Genocea Biosciences

— Pilot study to evaluate use of Cofactor assay in Genocea’s neoantigen vaccine clinical trial —December 04, 2018 09:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Cofactor Genomics, a clinical RNA sequencing and translational assay developer, today announced a pilot study to evaluate use of Cofactor’s ImmunoPrismTM assay in Genocea Biosciences’ Phase 1/2a clinical trial testing the... Read more

NRGene Announces Expanded Licensing Agreement with Bayer for the GenoMAGIC Platform

Following successful evaluation, Bayer has chosen the GenoMAGICTM platform to support its advanced molecular breeding program in several key crops Ness Ziona, Israel – (December 3, 2018) –NRGene, the worldwide leader in genomic analysis, announces a key milestone in its multi-year licensing agreement with Bayer for the use of GenoMAGICTM, a cloud-based big data analytics platform... Read more

Merck KGaA, Darmstadt, Germany, successfully divests Consumer Health

01 DEC 2018 | DARMSTADT, GERMANY Closing of sale to Procter & Gamble at a cash purchase price of € 3.4 billion completed Successful completion allows Merck KGaA, Darmstadt, Germany, to further focus on innovation driven businesses in Healthcare, Life Science and Performance Materials Transaction successfully closed within an ambitious timeframe  Merck KGaA, Darmstadt, Germany, a leading science and... Read more

Valens expands research collaboration with Thermo Fisher Scientific

KELOWNA, BC, Nov. 29, 2018 /PRNewswire/ – Valens GroWorks Corp. (CSE: VGW,OTC: MYMSF) (the “Company” or “Valens“), a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce it has established an expanded research collaboration agreement with Thermo Fisher Scientific.... Read more

Rigaku to partner with Covalent Metrology to deliver New Semiconductor Lab Resources in Silicon Valley

A new collaboration between Rigaku and Covalent will deliver state-of-the-art metrology capabilities to the semiconductor and electronics markets November 29, 2018 – Sunnyvale, CA. Rigaku Corporation, a global leader in X-ray analytical instrumentation, is pleased to announce a new partnership with Covalent Metrology, a leading provider of analytical services to advanced materials innovation companies. In a... Read more

AMETEK Acquires Spectro Scientific

BERWYN, Pa., Nov. 27, 2018 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Spectro Scientific, a leading provider of machine condition monitoring solutions for critical assets in high-value industrial applications. Spectro provides both lab-based and onsite instrumentation, consumables and cloud-based software analytics to help customers determine and monitor the... Read more

Spectro Scientific Acquired by AMETEK, Inc.

November 27, 2018 Spectro Scientific, one of the world’s largest suppliers of fluid analysis instrumentation and software, has been purchased by AMETEK, Inc. Spectro has annual sales of approximately $50 million and was acquired for approximately $190 million. Spectro was a privately held company and is headquartered in Chelmsford, Massachusetts. It joins AMETEK as part... Read more